UNSPSC 51183402: Mitiglinide

This classification denotes an anti-diabetic agent with the molecular formula C19H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) D86I0XLB13, chemically known as (-)-(2s,3a,7a-cis)-alpha-benzylhexahydro-gamma-oxo-2-isoindolinebutyric acid but more generally known as mitiglinide, which bears US NIH Compound Identifier 3047758. European Medicines Agency schedules Mitiglinide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08999MIG.

UNSPSC 51183402 Mitiglinide is a Commodity code for a specific prescription diabetes medication — a meglitinide-class oral antidiabetic agent used to manage type 2 diabetes. State and local governments procure this drug through health insurance plans, pharmacy benefit managers, and direct purchasing agreements for employee health benefits, Medicaid programs, and correctional-facility inmate care. The drug appears in state and local RFPs and RFQs as a line item within broader pharmaceutical procurement or managed-care contracts rather than as a standalone solicitation.

The source provides no recent state or local contract opportunities tagged to this code. Without visibility into active solicitations or awarded contracts, no issuing-body mix, geographic concentration, or representative opportunities can be confirmed from the available data.